A Study to Evaluate Safety, Tolerability, and Immunogenicity of SARS-CoV-2 Variant (COVID-19) mRNA Vaccines
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05434585 |
|
Recruitment Status :
Active, not recruiting
First Posted : June 28, 2022
Last Update Posted : February 8, 2023
|
Sponsor:
Suzhou Abogen Biosciences Co., Ltd.
Information provided by (Responsible Party):
Suzhou Abogen Biosciences Co., Ltd.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Active, not recruiting |
|---|---|
| Actual Primary Completion Date : | October 10, 2022 |
| Estimated Study Completion Date : | August 30, 2023 |